Home
About
Overview
Sharing Data
ORCID
Help
History (8)
Recipient of First Annual
Sugeng, Lissa
Apples to Oranges: Ethical Considerations in COVID-19 Surgical Recovery.
Production of [Formula: see text] and [Formula: see text] in proton-proton collisions at [Formula: see text] 7 TeV.
Principal Investigator
See All 8 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Tsuji, Takemasa
One or more keywords matched the following items that are connected to
Tsuji, Takemasa
Item Type
Name
Concept
Antigens, Neoplasm
Academic Article
Expression and immune responses to MAGE antigens predict survival in epithelial ovarian cancer.
Academic Article
Direct tumor recognition by a human CD4(+) T-cell subset potently mediates tumor growth inhibition and orchestrates anti-tumor immune responses.
Academic Article
Split T cell tolerance against a self/tumor antigen: spontaneous CD4+ but not CD8+ T cell responses against p53 in cancer patients and healthy donors.
Academic Article
A rare population of tumor antigen-specific CD4+CD8+ double-positive aß T lymphocytes uniquely provide CD8-independent TCR genes for engineering therapeutic T cells.
Academic Article
Heat shock protein 90-mediated peptide-selective presentation of cytosolic tumor antigen for direct recognition of tumors by CD4(+) T cells.
Academic Article
HLA superfamily assignment is a predictor of immune response to cancer testis antigens and survival in ovarian cancer.
Academic Article
Rapid Construction of Antitumor T-cell Receptor Vectors from Frozen Tumors for Engineered T-cell Therapy.
Academic Article
Epigenetic potentiation of NY-ESO-1 vaccine therapy in human ovarian cancer.
Academic Article
Antibody-targeted NY-ESO-1 to mannose receptor or DEC-205 in vitro elicits dual human CD8+ and CD4+ T cell responses with broad antigen specificity.
Academic Article
Nonclassical antigen-processing pathways are required for MHC class II-restricted direct tumor recognition by NY-ESO-1-specific CD4(+) T cells.
Academic Article
Tumor-infiltrating NY-ESO-1-specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer.
Academic Article
Enhancement of tumor-reactive cytotoxic CD4+ T cell responses after ipilimumab treatment in four advanced melanoma patients.
Academic Article
Overcoming regulatory T-cell suppression by a lyophilized preparation of Streptococcus pyogenes.
Academic Article
Phase I clinical trial of mixed bacterial vaccine (Coley's toxins) in patients with NY-ESO-1 expressing cancers: immunological effects and clinical activity.
Academic Article
Induction of regulatory T cell-resistant helper CD4+ T cells by bacterial vector.
Academic Article
Influence of CD4+CD25+ regulatory T cells on low/high-avidity CD4+ T cells following peptide vaccination.
Academic Article
Effect of Montanide and poly-ICLC adjuvant on human self/tumor antigen-specific CD4+ T cells in phase I overlapping long peptide vaccine trial.
Academic Article
Phase I trial of overlapping long peptides from a tumor self-antigen and poly-ICLC shows rapid induction of integrated immune response in ovarian cancer patients.
Academic Article
Characterization of preexisting MAGE-A3-specific CD4+ T cells in cancer patients and healthy individuals and their activation by protein vaccination.
Academic Article
Inducing efficient cross-priming using antigen-coated yeast particles.
Academic Article
The critical role of type-1 innate and acquired immunity in tumor immunotherapy.
Academic Article
Differential antigen expression profile predicts immunoreactive subset of advanced ovarian cancers.
Academic Article
Tcf-1 protects anti-tumor TCR-engineered CD8+ T-cells from GzmB mediated self-destruction.
Search Criteria
Antigens Neoplasm